Trial intelligence / Profile preview

Sivelestat sodium for postoperative ventilation in aortic dissection

NCT05874700Unknown

Start
May 2023
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial in acute lung injury (ALI) comparing Sivelestat sodium group with Placebo control group (2 arms). Primary endpoint: Invasive mechanical ventilation time. Status: unknown.

02

Drugs

sivelestat
03

Conditions

acute lung injury (ALI)

Beyond the preview

Go deeper on NCT05874700.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05874700.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call